New study tests heart failure Self-Care tools in italian patients
NCT ID NCT07608393
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study checks if two Italian questionnaires accurately measure how well people with heart failure care for themselves and how caregivers help. Researchers will enroll 1,000 patients and their caregivers across Italy. The goal is to improve heart failure management by using reliable self-care tools.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,000 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
500 patients with heart failure and 500 caregivers of patients with heart failure
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria for patients: * Ability to understand and speak Italian * Willingness to firm the informed consent form * Heart Failure for at least 3 months * Aged \>/= 18 years old Inclusion Criteria for caregivers: * Ability to speak and understand Italian * Being selected as principal caregiver by the patient * Aged \>/= 18 years old Exclusion Criteria: * cognitive impairment * surgery or heart attack in the last 3 months * having a LVAD
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?
- Can AI read heart ultrasounds as well as trained sonographers?
- Can modern heart failure drugs reverse damage in three months?